You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Epithelial Ovarian Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer

Terminated
  • Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Assess Safety and Effectiveness of Zirabev in Domestic Various

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +7 more
  • (no location specified)
Jun 30, 2022

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

Not yet recruiting
  • Prostate Cancer
  • +11 more
  • Guided physical exercise
  • +2 more
  • Tampere, Länsi-Suomi, Finland
    Tampere University Hospital
Apr 3, 2023

Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Epithelial Ovarian Cancer
  • AMG 794
  • Orange, California
    University of California at Irvine
Jan 25, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in India (Bevacizumab)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Vijayawada, Andhra Pradesh, India
  • +24 more
Apr 1, 2022

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting
  • Advanced Fallopian Tube Carcinoma
  • +10 more
  • Wee1 Inhibitor ZN-c3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 25, 2023

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022

Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide

Not yet recruiting
  • Ovarian Cancer Stage IV
  • +2 more
  • Washington, District of Columbia
  • +2 more
Jul 28, 2022

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Ovarian Cancer Trial in Guangzhou

Recruiting
  • Ovarian Cancer
    • Guangzhou, Guangdong, China
      The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit
    Feb 22, 2022

    Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

    Not yet recruiting
    • Head and Neck Cancer
    • +8 more
    • Tumor and HLA Profiling
    • (no location specified)
    Mar 31, 2023

    Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

    Completed
    • Ovarian Cancer
    • Breast Cancer
    • Ahmedabad, India
    • +15 more
    Oct 28, 2022

    Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

    Active, not recruiting
    • Metastatic Fallopian Tube Carcinoma
    • +11 more
    • Phoenix, Arizona
    • +13 more
    Dec 2, 2022

    Ovarian Cancer, Breast Cancer Trial in Vijayawada (Olaparib tablets, 150 mg, Lynparza® (olaparib) tablets 150 mg)

    Recruiting
    • Ovarian Cancer
    • Breast Cancer
    • Olaparib tablets, 150 mg
    • Lynparza® (olaparib) tablets 150 mg
    • Vijayawada, Andhra Pradesh, India
      Sandoz Investigative Site
    Apr 12, 2022

    Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +9 more
    • Saint Louis, Missouri
    • +4 more
    Dec 12, 2022

    Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Nov 3, 2022

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

    Recruiting
    • BRCA1 Gene Mutation
    • +19 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • New Brunswick, New Jersey
    • +1 more
    Nov 16, 2022

    Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or

    Terminated
    • Ovarian Cancer
    • Ovarian Neoplasms
    • 18F-EF5 PET/CT scan
    • Optional biopsy
    • Vancouver, British Columbia, Canada
      BC Cancer Agency - Vancouver Centre
    Feb 2, 2022